136 related articles for article (PubMed ID: 7913179)
1. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
Bingley PJ; Bonifacio E; Gale EA
Lancet; 1994 Jul; 344(8917):266-7. PubMed ID: 7913179
[No Abstract] [Full Text] [Related]
2. Combined antibody screening for improved prediction of IDDM--modern strategies.
Roll U; Ziegler AG
Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889
[No Abstract] [Full Text] [Related]
3. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
Bieg S; Seissler J; Scherbaum WA
Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923
[No Abstract] [Full Text] [Related]
4. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
[TBL] [Abstract][Full Text] [Related]
5. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
Bonifacio E; Bingley PJ
Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639
[No Abstract] [Full Text] [Related]
6. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
Thivolet C
Journ Annu Diabetol Hotel Dieu; 1992; ():165-71. PubMed ID: 1495236
[No Abstract] [Full Text] [Related]
7. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
Orrell RW; Lane RJ; Maitland J; Leslie RD
Lancet; 1994 Jul; 344(8917):267. PubMed ID: 7913180
[No Abstract] [Full Text] [Related]
8. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
9. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
Mandrup-Poulsen TR
Ugeskr Laeger; 2007 Jan; 169(4):300-4. PubMed ID: 17274923
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
11. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
Morimoto J; Maruyama T; Kasuga A; Ozawa Y; Kobayashi A; Funakoshi S; Iwasaki R; Suzuki Y; Shimada A; Saruta T
Diabetes Care; 1998 Nov; 21(11):2037-9. PubMed ID: 9802771
[No Abstract] [Full Text] [Related]
12. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetes islet autoantibody markers.
Winter WE; Harris N; Schatz D
Diabetes Technol Ther; 2002; 4(6):817-39. PubMed ID: 12614488
[TBL] [Abstract][Full Text] [Related]
14. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
15. Glutamate decarboxylase: an autoantigen in IDDM.
Clare-Salzler MJ; Tobin AJ; Kaufman DL
Diabetes Care; 1992 Jan; 15(1):132-5. PubMed ID: 1737532
[No Abstract] [Full Text] [Related]
16. [Autoantibodies in type 1 diabetes mellitus].
Ziegler M; Ziegler B
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
[No Abstract] [Full Text] [Related]
17. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Orban T; Sosenko JM; Cuthbertson D; Krischer JP; Skyler JS; Jackson R; Yu L; Palmer JP; Schatz D; Eisenbarth G;
Diabetes Care; 2009 Dec; 32(12):2269-74. PubMed ID: 19741189
[TBL] [Abstract][Full Text] [Related]
18. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
[No Abstract] [Full Text] [Related]
19. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus.
Petersen JS; Kyvik KO; Bingley PJ; Gale EA; Green A; Dyrberg T; Beck-Nielsen H
BMJ; 1997 May; 314(7094):1575-9. PubMed ID: 9169400
[TBL] [Abstract][Full Text] [Related]
20. Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.
Yu L
Methods Mol Biol; 2016; 1433():85-91. PubMed ID: 26659802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
